UBS Group
GMED icon

UBS Group’s Globus Medical GMED Stock Holding History

UBS Group’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-109,500
Closed -$9.56M – 10755
2025
Q4 		$9.56M Buy
+109,500
New +$8.31M ﹤0.01% 3331
2022
Q2 		– Sell
-30,000
Closed -$2.21M – 10548
2022
Q1 		$2.21M Buy
+30,000
New +$2.09M ﹤0.01% 3337

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

UBS Group's GMED Position: Q2 2026 in Review

UBS Group increased its Globus Medical (GMED) stake by 54% in Q2 2026, buying an estimated $24.7M and bringing the position to 834,191 shares worth $65.9M. The position accounts for 0.01% of the portfolio, ranked #1482.

UBS Group first reported a position in GMED in Q4 2014 and has held it in 47 quarters since. The position peaked at $73.8M in Q1 2025. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • UBS Group held 834,191 shares of Globus Medical worth $65.9M as of Q2 2026.
  • UBS Group bought 291,079 Globus Medical shares in Q2 2026, an estimated $24.7M.
  • Globus Medical made up 0.01% of UBS Group's portfolio in Q2 2026, its #1482 holding.
  • UBS Group first reported a position in Globus Medical in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's Globus Medical position peaked at $73.8M in Q1 2025.
  • 601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.